Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 901-910 of 3423 for cancer

Edit search filters
  1. A Study to Evaluate Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma

    Rochester, MN

  2. A Study Of Adjuvant Cretostimogene Grenadenorepvec For Treatment Of Intermediate Risk NMIBC Following TURBT

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  3. Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

  4. A Study to Assess the Antitumor Activity and Safety of IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects With Claudin 18.2 Positive, Metastatic Pancreatic Adenocarcinoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  5. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

  6. A Study to Examine the Effect of Ginger on the Gut Microbiome

    Mankato, MN

  7. Brightline-1: A Study to Compare Bi 907828 With Doxorubicin In People With a Type of Cancer Called Dedifferentiated Liposarcoma

    Jacksonville, FL, Rochester, MN

  8. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Study of INBRX-109 in Conventional Chondrosarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Safety of MT-401-OTS in Patients with Relapsed AML or MDS

    Jacksonville, FL

.

Mayo Clinic Footer